Ferroptosis is involved in cisplatin sensitivity of the S3 segment of immortalized proximal tubule cells. 2024

Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, 770-8514, Japan.

Cisplatin (CDDP) is administered as an anticancer drug across a broad spectrum of cancer treatments, but it causes severe renal damage. Several studies have attempted to elucidate the cause of CDDP-induced renal injury, but the detailed mechanism remains unclear. We previously found that S3 cells are more sensitive to CDDP than S1 and S2 cells by using immortalized cells derived from S1, S2, and S3 segments of proximal tubules. In this study, we investigated the potential contribution of reactive oxygen species (ROS) to the sensitivity of S3 cells to CDDP. The results showed that S3 cells have high sensitivity to CDDP, paraquat (PQ) and three ROS substances. To examine the mechanisms underlying the sensitivity to ROS in S3 cells, we compared the cellular responses of CDDP- and PQ-exposed S3 cells. The results indicated that the levels of intracellular ROS and lipid peroxides were increased in S3 cells after CDDP and PQ exposure. The intracellular levels of antioxidant proteins such as thioredoxin, thioredoxin reductase 1 and glutathione peroxidase 4 were also increased by exposure to PQ, but these proteins were decreased by CDDP exposure in S3 cells. Furthermore, the levels of intracellular free Fe2+ were increased by CDDP exposure only in S3 cells but not S1 or S2 cells, and cytotoxicity by exposure to CDDP in S3 cells was suppressed by ferroptosis inhibitors. These results suggested that the induction of ferroptosis due to the ROS production through attenuation of the antioxidant system and elevated free Fe2+ is partly responsible for the sensitivity of S3 cells to CDDP.

UI MeSH Term Description Entries

Related Publications

Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
May 1986, Kidney international,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
April 2023, Scientific reports,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
September 1997, Kidney international,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
October 1992, Pflugers Archiv : European journal of physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
February 1997, The Journal of general physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
September 1988, The Journal of general physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
October 1989, The American journal of physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
March 1997, The American journal of physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
February 1995, The American journal of physiology,
Hiroki Taguchi, and Daigo Sumi, and Seiichiro Himeno, and Hitomi Fujishiro
February 1995, The American journal of physiology,
Copied contents to your clipboard!